Tempus announces collaboration with northwestern university's abrams research center on neurogenomics to leverage ai for alzheimer's disease research

Chicago--(business wire)--tempus ai, inc. (nasdaq: tem), a technology company leading the adoption of ai to advance precision medicine and patient care, today announced a collaboration with the abrams research center on neurogenomics at northwestern university feinberg school of medicine. this multi-year collaboration aims to harness ai for rapid discovery and innovation in alzheimer's disease research. the collaboration leverages tempus' ai-powered data analytics platform, lens, to analyze and.
TEM Ratings Summary
TEM Quant Ranking